Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12

Bristol-Myers announces FDA approval of Opdivo

Bristol-Myers announced the U.S. FDA has approved Opdivo injection for intravenous use for the treatment of patients with hepatocellular carcinoma who have been previously treated with sorafenib. Approval for this indication has been granted under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials. In the CheckMate -040 trial, 14.3%* (95% CI: 9.2-20.8; 22/154) of patients responded to treatment with Opdivo. The percentage of patients with a complete response was 1.9% (3/154) and the percentage of patients with a partial response was 12.3% (19/154). Among responders (n=22), responses ranged from 3.2 to 38.2+ months; 91% of those patients had responses of six months or longer and 55% had responses of 12 months or longer.

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

BMY Bristol-Myers
$63.36

0.03 (0.05%)

09/12/17
09/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Neutral from Long-Term Buy at Hilliard Lyons with analyst Kurt Kemper citing share appreciation as shares have approached his previous $65 price target. 2. Bunge (BG) downgraded to Hold from Buy at Vertical Group citing the acquisition of 70% interest in IOI Loders Croklaan. 3. Advance Auto Parts (AAP) downgraded to Sell from Neutral at Citi with analyst Kate McShane saying the company's turnaround seems to be taking longer given the number of issues to fix, and its cost savings are unlikely to impact earnings given its needed investments. 4. Precision Drilling (PDS) downgraded to Neutral from Overweight at JPMorgan. 5. Nucor (NUE) and Steel Dynamics (STLD) were downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/17
DBAB
09/15/17
NO CHANGE
Target $20
DBAB
Buy
Halozyme price target raised to $20 from $17 at Deutsche Bank
Deutsche Bank analyst Andrew Peters raised his price target for Halozyme (HALO) to $20 saying he's bullish following the new Enhanze partnership. Yesterday's dual announcements for additional Enhanze collaborations are "clear positives" for the stock, Peters tells investors in a research note. He says the size of the Bristol-Myers Squibb deal, including the upfront payment, is larger than expected. The analyst reiterates a Buy rating on Halozyme.
09/15/17
JEFF
09/15/17
NO CHANGE
Target $72
JEFF
Buy
Bristol-Myers price target raised to $72 from $66 at Jefferies
Jefferies analyst Jeffrey Holford raised his price target for Bristol-Myers Squibb to $72 saying new opportunities for the Opdivo/Yervoy combo offer upside to estimates. The analyst says this, along with higher estimates for Eliquis and "significant" margin expansion over the mid term support his higher price target. Holford keeps a Buy rating on Bristol.
09/18/17
JEFF
09/18/17
NO CHANGE
JEFF
AbbVie remains top global Pharma pick at Jefferies
Jefferies analyst Jeffrey Holford says AbbVie (ABBV) remains his top global pick in Pharmaceuticals, followed by Bayer (BAYRY). In the U.S., the analyst lists Zoetis (ZTS), Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) as his top picks behind AbbVie. Merck (MRK) and Novo Nordisk (NVO) are the analyst's least preferred stocks. Holford cut his price target for Underperform-rated Merck to $52 from $55 and raised his price target for Buy-rated Zoetis to $77 from $74.

TODAY'S FREE FLY STORIES

SNE

Sony

$49.55

0.74 (1.52%)

08:21
02/20/18
02/20
08:21
02/20/18
08:21
Periodicals
Sony to start ride-hailing service in Japan as Uber eyes expansion, CNBC says »

Sony has partnered with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PATK

Patrick Industries

$66.05

-2 (-2.94%)

08:21
02/20/18
02/20
08:21
02/20/18
08:21
Hot Stocks
Patrick Industries sees Metal Moulding acquisition 'immediately accretive' »

Patrick Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

, GPP

Green Plains Partners

$18.00

0.2 (1.12%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Delek Logistics, Green Plains Partners announce formation of logistics JV »

Delek Logistics Partners…

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

GPP

Green Plains Partners

$18.00

0.2 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

YUM

Yum! Brands

$78.25

-0.72 (-0.91%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Periodicals
Yum's KFC U.K. restaurants facing chicken shortage, shutting branches, FT says »

Yum's KFC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$189.34

-0.7 (-0.37%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Perrigo confirms patent challenge with FDA for generic version of Finacea Foam »

Perrigo Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

XLK

Technology Select Sector SPDR

$67.18

-0.1 (-0.15%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

, CSRA

CSRA

$40.56

0.04 (0.10%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Recommendations
General Dynamics, CSRA analyst commentary  »

General Dynamics price…

GD

General Dynamics

$224.19

-1.21 (-0.54%)

CSRA

CSRA

$40.56

0.04 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EEM

MSCI Emerging Markets Index

$49.54

-0.16 (-0.32%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technical Take: MSCI Emerging Markets ETF falls in early trading »

The MSCI Emerging Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$68.12

-0.17 (-0.25%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$104.79

-0.51 (-0.48%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$60.48

-0.22 (-0.36%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$2.96

0.024 (0.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Upgrade
Bombardier rating change  »

Bombardier upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$50.12

0.44 (0.89%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$32.38

-0.05 (-0.15%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Recommendations
Planet Fitness analyst commentary  »

Planet Fitness price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

XLP

Consumer Staples Sector SPDR

$55.60

0.22 (0.40%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$85.41

0.61 (0.72%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$69.34

1.24 (1.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Periodicals
Cardinal accused by Kentucky AG of contributing to opioid epidemic, Reuters says »

Cardinal Health has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Steel Dynamics raises dividend 21% to 18.75c »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$153.34

0.54 (0.35%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLNO

Soleno Therapeutics

$1.62

-0.11 (-6.36%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Soleno Therapeutics announces successful end-of-Phase II meeting with FDA »

Soleno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$251.96

0.11 (0.04%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$53.83

0.08 (0.15%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Technical Take: HSBC falls after results »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

SPY

SPDR S&P 500 ETF Trust

$273.11

0.08 (0.03%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$28.98

-0.04 (-0.14%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.